Editorial Board ::: Current Drug Delivery

ISSN: 1875-5704 (Online)
ISSN: 1567-2018 (Print)


Volume 14, 8 Issues, 2017


Download PDF Flyer




Current Drug Delivery

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Xing-Jie Liang
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety
National Center for Nanoscience and Technology of China
Beijing
P.R.China


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.516
5 - Year: 2.338

Editorial Board

Editor-in-Chief:

Xing-Jie Liang (Biography
Xing-Jie Liang

Dr. Xing-Jie Liang got his Ph.D at National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing. Dr. Liang also holds a postdoc with Dr. Michael M. Gottesman (Deputy Director of NIH, USA) for 5 years at Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Currently Dr. Liang is deputy director of Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences and Lab Chief of Laboratory of Controllable Nanopharmaceuticals, National Center for Nanoscience and Technology of China. He has published more than 80 scientific publications..

)

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety
National Center for Nanoscience and Technology of China
Beijing
P.R.China



Co-Editors:

Yoshihiro Hayakawa
Faculty of Engineering Department of Applied Chemistry Aichi Institute of Technology 1247 Yachigusa, Yakusa-cho
Toyota, Aichi 470-0392
Japan

Manmohan Singh (Biography
Manmohan Singh

Manmohan Singh, is currently the Head of Technical Development (TD) within Novartis Vaccines in Holly Springs, NC USA. He joined NVD TD in 2012 and prior to that had spent 16 years in the Research Division of formerly Chiron and now Novartis Vaccines. He was part of the Chiron/NVD vaccines research team that over the years has developed several innovative antigen and adjuvant delivery technologies. He is a licensed Pharmacist and holds a Masters and a PhD in Pharmaceutics from the National Institute of Immunology, New Delhi India. He is the author of over 120 original research publications, editor of four books on vaccine research and development and is an inventor on over 47 issued patents.

)

Novartis Vaccines Vaccine Delivery Group 4560 Horton Street, MS 4.3
Emeryville, CA 94608
USA

David S. Jones (Biography
David S. Jones

David Jones, Professor of Biomaterial Science at Queen’s University Belfast and Pro-Vice-Chancellor for Education and Students. He holds BSc (1st class honours) in Pharmacy (1985), a PhD in Pharmaceutics (1988), in 2006, a DSc., all from Queens University of Belfast. More recently (2014) he gained a BA (1st class honours) in Mathematics and Statistics from the Open University. Since 1999 he holds a personal Chair (in Biomaterial Sciences) at the School of Pharmacy, Queens University of Belfast. His research concerns the characterisation, formulation and engineering of pharmaceutical materials/dosage forms and biomedical devices. He is the author of three textbooks, 10 patents and over 400 research papers.

)

School of Pharmacy,Queen's University of Belfast,Medical Biology Centre,97, Lisburn Road
Belfast, BT9 7BL
UK

Hiraku Onishi
Department of Drug Delivery Research Hoshi University, 2-4-41, Ebara Shinagawa-ku
Tokyo, 142-8501
Japan


Assistant Editor(s):

Joanne Blanchfield
School of Molecular and Microbial Sciences University of Queensland
Brisbane
Australia


Associate Editors:

Maria C. Bonferoni (Biography
Maria C. Bonferoni

Dr Maria Cristina Bonferoni Graduated in 1984 and got PhD in 1991 in Pharmaceutical Chemistry and Technology. She is associate professor since 2001, at the Department of Drug Sciences, University of Pavia. The research interests concern pharmaceutical development of conventional and controlled release formulations. Early work involved the study of hydrophilic polymers for oral matrix tablets. Swelling/erosion and diffusion/dissolution processes occurring in hydrophilic matrices have been studied and related to polymer rheological behaviour (viscosity and viscoelasticity) under different conditions of pH and ionic strength. Other research interest involved mucoadhesion mechanisms, development of mucoadhesive dosage forms and of methods to measure mucoadhesion properties. Dr Bonferoni is author of about 140 scientific papers, 12 patents, 12 book chapters.

)

University of Pavia
Pavia
Italy

Sam T. Mathew (Biography
Sam T. Mathew

Sam T. Mathew is an experienced pharmaceutical research professional who is currently working as a Global Head: Clinical eSubmission and Technical Compliance Delivery at GlaxoSmithKline Vaccines. Also worked with Accenture Pharmaceutical services, Bangalore, India as Process Lead in Medical/Publication/Scientific writing. Prior to this worked with Novartis Pharmaceuticals, Hyderabad, India as Senior Publication Writer/Senior Scientific Writer. Previously, worked as Scientist-Formulation development in managerial grade at Viziphar biosciences, Bangalore, India. He is a doctorate in pharmacy (Pharmaceutics), has the credit of the academic research >25 scientific research/review articles are published in peer reviewed international journals. Presented papers at 3 international and 9 national conferences.

)

GlaxoSmithKline Vaccines
Bangalore
India

Xue Xue (Biography
Xue Xue

Dr. Xue Xue obtained her Ph.D at National Center for Nanoscience and Technologies, Chinese Academy of Sciences, with her mentor Dr. Xing-jie Liang. From 2012 to 2014, she studied in New York University as a visiting scholar. Then she was an assistant professor with Dr. Hong Zhang at National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences. Dr. Xue is currently a principle investigator in State Key Laboratory of Medicinal Chemical Biology/College of Pharmacy, and lab chief of Laboratory of Theranostic Nanomedicine in Nankai University. In recent five years, she has authored over 15 SCI-indexed papers with total IF > 150.

)

Nankai University
Tianjin
P.R. China


Editorial Board Members:

A. Agrawal (Biography
A. Agrawal

Dr. Ajay K Agrawal received his doctorate in Chemistry, and conducted his post- doctoral research in the Faculty of Medicine, University of Alberta, Canada and Molecular Cell Pathology, Royal Free Hospital, London on novel targeted cancer drug delivery therapeutics and imaging systems based on pegylation. He has been in the board of directors of several biotech and pharma companies in UK, Europe and USA, including the development board of Buckingham Medical School. Dr. Agrawal has been in the editorial board of number of journals, published by Bentham Science Publishers. One of his invited review articles was cited in the “Current Awareness in Biomedicine: Drug Targeting Bulletin” after being scanned in over 2,500 journals.

)

DyoDelta Biosciences Ltd
Edmonton
Canada

H.O. Alpar (Biography
H.O. Alpar

Dr. H. Oya Alpar is Emeritus Professor at the UCL School of Pharmacy, University of London and Head of the Department of Pharmaceutical Technology at the University of Kemerbugaz. Previously, Prof. Alpar was the Head of Centre for Drug Delivery Research (CDDR) running a large multi-disciplinary research group at The School of Pharmacy. Prof Alpar has extensive experience in area of investigation and development of protein and DNA based vaccine micro and nano encapsulation technologies. Prof. Alpar is a progressive expert in the field of micro and nanoparticle technology, use in vaccination and delivery of other challenging biotherapeutics including siRNA.

)

University of London
London
UK

H.A.E. Benson (Biography
H.A.E. Benson

Dr. Heather A.E. Benson leads the Skin Delivery Research Group and has an international reputation for her research in the area of skin biology and drug/peptide delivery. She has published over 100 peer reviewed publications related to drug delivery. Dr. Benson obtained her Pharmacy degree and PhD (Skin Drug Delivery) from Queen's University, Belfast and has held research and academic positions at the University of Queensland and University of Manitoba before joining Curtin University in 2001. Dr. Benson's current research areas are in drug targeting to the skin using physical, chemical and formulation enhancement techniques; delivery of therapeutic peptides by novel formulations/delivery systems including nanosystems.

)

Curtin University of Technology
Perth
Australia

B. Boyd (Biography
B. Boyd

Dr. Benjamin Boyd is a Professor in the Monash Institute of Pharmaceutical Sciences. He is also a Chief Investigator in the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology.

Ben’s status as a global authority on drug development and delivery has seen him interviewed by journalists working for a variety of news platforms including The Australian, Herald Sun and ABC Radio.

)

Monash University (Parkville Campus)
Parkville
Australia

M. R. Doschak (Biography
M. R. Doschak

Dr. Michael Doschak is an Associate Professor with the Faculty of Pharmacy & Pharmaceutical Sciences at the University of Alberta in Edmonton, Canada. He received his Ph.D. (2004) in the Medical Sciences with the Faculty of Medicine at the University of Calgary, where his research centered on the mineral binding effects of the bisphosphonate drug family during the pathogenesis of Osteoarthritis. He completed his initial Postdoctoral Fellowship in Drug Delivery under the supervision of Prof. Hasan Uludag at the University of Alberta, followed by an Industrial Fellowship with the Canadian biotech company Millenium Biologix Corporation Biologics Division labs in Mississauga.

)

University of Alberta
Edmonton, AB
UK

H. Gu (Biography
H. Gu

Prof. Haigang Gu, Ph. D., is a Postdoctoral Fellow working In the Dr. Zhang’s laboratory, Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN USA. Dr. Gu is interested in developing different protocols to induce dopaminergic neuronal differentiation in pluripotent stem cells. Using immnunostaining and super resolution live imaging, he is also studying synaptic maturity and transmission in differentiated dopaminergic neurons.

)

Vanderbilt University
Nashville, TN
USA

H. Ichikawa (Biography
H. Ichikawa

Dr. Hideki Ichikawa is Doctor of Philosophy (Ph.D.), in Pharmaceutics and Drug Delivery. Dr. Ichikawa is currently affiliated with Kobe Gakuin University as Head of the Division of Faculty of Pharmaceutical Sciences from 2011 till present. Dr. Ichikawa’s Field of interests involves Medicine, Pharmacy, Pharmaceutical Research, Drug Delivery, Fluidized bed coating, Nanoparticle Technology. Dr. Hideki Ichikawa has contributed in more than 117 publications.

)

Kobe Gakuin University
Kobe
Japan

H.-W. Kim (Biography
H.-W. Kim

Dr. Hae-Won Kim received his PhD from the Soul National University, South Korea, in 2002. He was a visiting scientist at the National Institute of Standards and Technology (NIST, 2000), and a Postdoctoral Fellow at University College London (UCL) Eastman Dental Institute (2003-2004) and Seoul National University Advanced Materials Research Institute (2004-2005). His research interests include tissue engineering, stem cell engineering, biointerface control and therapeutic scaffolds for muscle, nerve, blood vessel, bone and tooth structures. He is currently a Director of the Institute of Tissue Regeneration Engineering (ITREN), and leads BK21+ Nanobiomedical Science Department. He is currently the editor-in-chief of the Journal of Tissue Engineering. He has published over 350 peer-reviewed papers.

)

Dankook University
Cheonan, 330-714
Republic of Korea

M. Lebl (Biography
M. Lebl

Dr. Michal Lebl graduated from The University of Chemical Technology, Prague Czech Republic (1974). He holds a PhD in organic chemistry from the Institute of Organic Chemistry and Biochemistry of the Czechoslovak Academy of Sciences in Prague (1978). Dr. Lebl is the inventor of the tilted centrifugation method of oligonucleotide synthesis, which he developed at Trega Biosciences, Inc. Dr. Lebl was able to raise funds to develop this technology through SBIR grants from NIH. Dr. Lebl has published over 230 scientific papers and he is the co-inventor of over 50 patents.

)

Illumina, Inc.
San Diego
USA

A. Margaritis (Biography
A. Margaritis

Dr. Argyrios Margaritis is Executive Editor and Professor Biochemical Engineering, Department of Chemical and Biochemical Engineering, University of Western Ontario, London, Ontario, CANADA. He has received a PhD in Biochemical Engineering from the University of California, Berkeley, U.S.A. He has authored about research publications that include 202 review articles, and 10patents, and he has given 201 Conference presentations. He is a Fellow of Engineers Canada and Fellow of Chem. Inst. Canada. He is serving as the President and CEO of Biomar Inc. Dr. Margaritis’ research interests are Biochemical and Biomedical Engineering, Bio-Environmental Engineering, Biofuels and Biopolymers.

)

The University of Western Ontario, London
Ontario
Canada

F. Peri (Biography
F. Peri

Francesco Peri is Professor of Organic and Medicinal Chemistry at the Department of Biotechnology and Biosciences, University of Milano-Bicocca, Italy. his research focused on the rational design and synthesis of new molecules (mainly glycolipids) capable to interact with innate immunity receptors MD-2 and CD14, thus interfering with the molecular processes of TLR4 activation and signaling. Several generation of TLR4 antagonists were patented and some of these compounds (IAXO molecules, Adipogen) are now commercially available as selective TLR4 blockers. He coordinates the Marie Curie ETN EU project 642157 (2015-2019)– TOLLerant (Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach), network consists of 8 academic and 2 industrial full partners representing 5 countries all across Europe and 3 associate partners, 2 from Europe and one from USA.

)

University of Milano
Milano
Italy

L. Prokai (Biography
L. Prokai

Dr. Laszlo Prokai is the UNT Health Science Center’s first Chair in Biochemistry endowed by the Houston-based Welch Foundation, one of the United States' oldest and largest private funding sources for chemical research. Dr. Prokai has maintained an actively funded research program supported by the National Institutes of Health (NIH) and is recognized nationally and internationally for his work on discovery, medicinal chemistry and chemical biology of central nervous system agents, the chemical biology of neuropeptides and proteomics, as well as mass spectrometry. He also serves as Courtesy Professor in the Departments of Medicinal Chemistry and Anesthesiology at the University of Florida.

)

University of North Texas Health Science Center
TX
USA

B. Rihova (Biography
B. Rihova

Blanka Rihova is Professor of Immunology, Charles University, Prague, the Czech Republic and Adjunct Professor of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, USA. In 2000–2007 she was a director of the Institute of Microbiology, Academy of Sciences of the Czech Republic. She is president of Czech Immunology Society, vice-president of Czech Learned Society and vice-president of Scientific Council of CAS. She is author or co-author of more than 250 scientific publications citied more than 4 000 times. Her H index = 40. Recently, she is mainly involved in development of targeted cytostatic drugs and experimental immunooncotherapy. She is regular reviewer of a number of scientific journals.

)

Institute of Microbiology
Czech Republic

P. Rovero (Biography
P. Rovero

Prof. Paolo Rovero, graduated in organic chemistry with the University of Florence in 1983 and specialized in peptide chemistry with the University of Sherbrooke, Quebec, Canada, in 1985. Since 1985, his research interests are related to the design, synthesis, conformational analysis and biological characterization of peptides of pharmaceutical interest. 180 scientific publications on international journals and 20+ patents of pharmaceutical relevance. He is a member of the Italian Chemical Society, of the European Peptide Society and of the American Peptide Society (charter member). Currently he is the Associate professor of medicinal chemistry. Since 1985, my skills and expertise are related to the design, synthesis, conformational analysis and biological characterization of peptides of pharmaceutical and diagnostic interest.

)

Universita' di Firenze
Firenze
Italy

M. Skwarczynski (Biography
M. Skwarczynski

Dr M. Skwarczynski received a Master degree in biotechnology and a PhD in chemistry from Wroclaw University of Technology (Poland). In 2004 he was awarded Japan Society for the Promotion of Science Postdoctoral Fellowship, and a grant to conduct research on paclitaxel.His research interest lies in the general area of medicinal chemistry and more recently in the development of nanomaterials for biomedical applications, vaccine delivery strategies, including design, chemoselective synthesis, conformational studies, and immunological properties of lipopeptide and polymer assembled multivalent vaccine candidates. He is author of over 70 journal articles and book chapters.

)

The University of Queensland
St Lucia, QLD
Australia

V. Torchilin (Biography
V. Torchilin

Vladimir P. Torchilin, Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, Mass. He graduated from the Moscow University with MS in Chemistry, and also obtained his Ph.D. and D.Sc. in Polymer Chemistry, Chemical Kinetics and Catalysis, and Chemistry of Physiologically Active Compounds in 1971 and 1980, respectively. His main interests include drug delivery and targeting, nanomedicine, multifunctional, stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy, cancer immunology, novel imaging agents. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 10 books and holds more than 40 patents.

)

Northeastern University
Boston, MA
USA

D.W. Wang (Biography
D.W. Wang

Dr. Daowen Wang has done PhD. from Tongji Medical University in 1992. He has done Postdoctoral Research from Department of Medicine, Vanderbilt University, United States in 1998. His research interest are in the field of Molecular Cardiology, translational medicine, molecular biology, cardiovascular internal medicine. Currently Dr. Wang is professor at Huazhong University of Science and Technology. He is vissitign facuty member at diferent internation universities.

)

Huazhong University of Science and Technology (HUST)
Rep. of China 430030

X. Wu (Biography
X. Wu

Dr. Xiao Wu is a Research Scientist in Formulation Development at Eli Lilly and Company in the US where she serves as a technical lead in development of early and commercial phase pharmaceutical formulations. She received her pharmacy degree (2003) from Peking University in China and Ph.D. (2008) in Pharmaceutics from the University of Bath, UK. Her Ph.D. research work focused on skin barrier function characterization, transdermal drug delivery, enhancement of percutaneous absorption, the prediction and assessment of skin penetration and topical bioavailability and nanotechnology. She is the author and co-author of 14 publications, and presented her research at more than 10 national and international conferences.

)

Eli Lilly and Company
Greenfield, IN
USA

H. Ai (Biography
H. Ai

Hua Ai received his Ph.D. in Biomedical Engineering from Louisiana Tech University in 2002. Following his doctoral studies, he completed his postdoctoral training in Biomedical Engineering at Case Western Reserve University in Cleveland, Ohio. In June 2005, Dr. Ai joined the National Engineering Research Center for Biomaterials, Sichuan University, as a Professor of Biomaterials. Currently, he also holds a joint appointment at the Department of Radiology, West China Hospital, Sichuan University. His group focuses on the design and application of self-assembly of nanobiomaterials for tumor molecular imaging and drug delivery.

)

National Engineering Research Center for Biomaterials, Sichuan University
Chengdu
China

P. Artursson (Biography
P. Artursson

Per Artursson is a professor in Dosage Form Design at the Department of Pharmacy, Uppsala University, Sweden where he heads the Drug Delivery research team. He is also Director for the Uppsala University drug optimization and pharmaceutical profiling platform within Science for Life Laboratories. His research aims at understanding drug absorption, distribution, metabolism and elimination (ADME) at the molecular and cellular level in order to deliver drugs more effectively via the oral route. He also investigates the effects of drug transporting proteins on drug disposition and drug interactions. He has published over 200 research articles and reviews, is highly cited and has received several international awards for his research.

)

Biomedical Centre
Uppsala
Sweden

P. Blasi (Biography
P. Blasi

Dr. Paolo Blasi graduated at the College of Pharmacy of the University of Perugia in 2002 and approved the Pharmacist Italian Board Exam obtaining the PharmD. In 2006 he received the Doctorate Degree (Ph.D.) in Pharmaceutical Technology from the same institution, discussing a thesis entitled “Multicompartment Systems for Modified Release of Drugs”.

He spent one year at the Université Louis Pasteur (Strasbourg, France) under the supervision of Prof. Pascal Wehrlé and 14 months at the University of Kentucky(Lexington, KY) in Prof. Patrick P. DeLuca’s laboratories.

He is co-author of 45 scientific articles, published in international peer-reviewed journals.

)

University of Camerino
Camerino
Italy

S.T. Chen (Biography
S.T. Chen

Dr. Shui-Tein Chen is working as Adjunct Research Fellow at Institute of Biochemical Sciences, National Taiwan University, Taiwan. Dr. Chen has completed his Ph.D., from Biochemistry, Natl Taiwan Univ. in 1989. His fields of expertise are Systems biology research. Systems biology simultaneously studies the complex interaction of many levels of biological information - genomic DNA, mRNA, proteins, functional proteins, informational pathways and informational networks -to understand how they work together.

Enzymes in organic synthesis. synthesis of biologically active amino acids, peptides, proteins, resolution of chiral drugs, Searching for stable biocatalysts, Development of new enzymatic procedures for organic synthesis.

)

Institute of Biological Chemistry
Taipei
Taiwan

V. Ferro (Biography
V. Ferro

Dr Valerie Ferro is currently working as Lecturer at Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, Scotland. Prof. Val Ferro graduated in Biochemistry at the University of Aberdeen (BSc Hons 1985) and carried out postgraduate research into Tumour Biology at the University of St. Andrews. (PhD, 1989). She moved to the University of Strathclyde in 1989 as a Postdoctoral Research Fellow, managing commercially-funded projects on vaccine development. She became a lecturer in 2006.

)

University of Strathclyde
Glasgow
UK

B. He (Biography
B. He

Prof. Bin He is PhD. in Polymer Chemistry & Physics, Institute of Chemistry, Chinese Academy of Sciences (CAS), 2003.Dr. HE is currently Professor at National Engineering Research Center for Biomaterials, Sichuan University, China. Dr. He was serving as Research Fellow at Nanyang Technological University in 2004. His fields of expertise are Biodegradable Polymers, Drug/Gene Delivery, Supramolecular Self-assembly. He was also awarded by National Science Foundation for Excellent Young Scholars, NSFC in 2012.

)

Sichuan University
Chengdu
China

T. Inazu (Biography
T. Inazu

Dr. Toshiyuki Inazu, PhD. is currently working as Laboratory Head at Tokai University, Department of Applied Chemistry, Hiratsuka, Kanagawa, Japan. Dr. Inazu’s Skills and Expertise involve Synthesis, Proteins, Organic Synthesis, Synthetic Organic Chemistry, Enzymes, Peptides, Peptide , Chemistry, Carbohydrate Chemistry, Amino Acids, Glycosylation, and Glycobiology. He has been contributed in 123 Research publication so far. He worked as a senior researcher at Noguchi Institute Tokyo, Japan form 1982 till 2003.

)

Tokai University
Kanagawa
Japan

J. H. Kopeček (Biography
J. H. Kopeček

Prof. Jindřich Henry Kopeček, received his Ph.D. in Macromolecular Chemistry from the Institute of Macromolecular Chemistry and D.Sc. in Chemistry from the Czechoslovak Academy of Sciences, Prague, Czech Republic. He is currently Distinguished Professor of Bioengineering and Distinguished Professor of Pharmaceutical Chemistry at the University of Utah. He is an elected member of the US National Academy of Engineering (2011). His research interests are focused on biorecognition of macromolecules, bioconjugate chemistry, drug delivery systems, self-assembled biomaterials, and drug-free macromolecular therapeutics. Kopeček is a coauthor of more than 430 scientific papers; his Hirsch index is 85 and his publications have been cited 25,400 times.

)

University of Utah (UT)
Salt Lake City
USA

J. Li (Biography
J. Li

Prof. Jun Li completed his PhD. from Osaka University, Japan in 1995. He is currently Associate Professor at the Department of Bioengineering, National University of Singapore, Singapore. Dr. li has completed his M.Sc., from Osaka University, Japan in 1992. His Research interests involves Design of Novel Biodegradable Polymers and Hydrogels, Self-assembly and Nano-Structures of Novel Macromolecular Systems, Applications of Novel Biomaterials for Drug/Gene Delivery and Tissue Engineering. Dr. Li has published over 149 scientific papers.

)

National University of Singapore
Singapore

L. Otvos (Biography
L. Otvos

Laszlo Otvos is Associate Editor for Current Protein and Peptide Science and Regional Editor for Protein and Peptide Letters. An organic chemist by education, he received his PhD degree from the Hungarian Academy of Sciences, Budapest in 1991 for developing novel chemical technologies in order to identify and characterize immunologically active peptides and processes in Alzheimer’s disease and anti-viral vaccine development. Later his research repertoire was extended to antimicrobial peptides and peptidic modulators of adipokine receptor responses focusing on cancer and cardiovascular/metabolic disease research. An author of more than 200 peer-reviewed papers with over 14,000 references to his publications, Laszlo Otvos is among the top 1% most cited researchers in the life science arena.

)

OLPE
Audubon, PA
USA

Y. Perrie (Biography
Y. Perrie

Dr. Yvonne Perrie is Chair Person in Drug Delivery within the University of Strathclyde. In 1998, she gained her PhD from the University of London investigating the role of liposomes for drug delivery. Dr. Perrie is an internationally recognised researcher with a strong track-record of high impact publications; with approximately 100 peer reviewed manuscripts and 5 textbooks. Her research is multi-disciplinary and is focused on the development of drug delivery systems to facilitate the delivery of drugs and vaccines, thus providing practical solutions for current healthcare problems.

)

University of Strathclyde
Glasgow
UK

T. Rades (Biography
T. Rades

Prof. Dr. Thomas Rades is currently Reseach Chair in Pharmaceutical Design and Drug Delivery Faculty of Health and Medical Sciences, Department of Pharmacy, University of Copenhagen, Universitetsparken København , Denmark. His research interests include the solid state of drugs and dosage forms, and Nanoparticles as delivery systems for drugs and vaccines. Research in both areas aims to improve drug therapy through appropriate formulation and characterisation of medicines and to increase understanding of the physico-chemical properties of drugs and medicines. It combines physical, chemical, and biological sciences and technology to optimally formulate drugs and vaccines for human and veterinary uses.

)

University of Otago
Dunedin
New Zealand

M. Roberts (Biography
M. Roberts

Michael (Mike) S. Roberts PhD DSc is a NHMRC Senior Principal Research Fellow, Professor of Therapeutics & Pharmaceutical Science at the University of South Australia; Professor of Clinical Pharmacology & Therapeutics at The University of Queensland and is Director of the Therapeutics Research Centre (TRC), based at the Princess Alexandra Hospital (Brisbane) and The Queen Elizabeth Hospital (Adelaide). His research outputs include: 7 books, more than 450 peer reviewed research publications, >50 book chapters; > 200 invited international talks and a leader of research teams funded by Australian and International Research bodies. He has recently been elected a Fellow of the Australian Academy of Health & Medical Science.

)

University of Queensland
Queensland
Australia

F. Shakeel (Biography
F. Shakeel

Dr. Faiyaz Shakeel received a Master degree (M. Pharm) and a PhD in Pharmaceutics from Jamia Hamdard (Hamdard University, New Delhi, India). At Jamia Hamdard. In 2011, he was awarded Young Scientist Award from the Association of Pharmacy Professionals (APP). In March 2016, he has been promoted to Associate Professor at King Saud University. At King Saud University, He also had very good expertise in solubilization of drug molecules using cosolvency models. His research interest lies in the general area of Pharmaceutics and more recently in the development of nanoemulsions and self-nanoemulsifying formulations for therapeutic applications. He is author of over 180 journal articles and book chapter.

)

King Saud University
Riyadh
Saudi Arabia

C. Strachan (Biography
C. Strachan

Professor Clare J Strachan completed a PhD in 2005 at the University of Otago, New Zealand entitled \"Spectroscopic investigation and quantitation of polymorphism and crystallinity of pharmaceutical materials\" which involved the use of Raman spectroscopy, terahertz pulsed spectroscopy and second harmonic generation. She then took up a postdoctoral position with Prof Jukka Rantanen in Helsinki, and subsequently became a University Researcher and Group Leader there. After a three year period back to the University of Otago as Lecturer/senior Lecturer, she returned to the University of Helsinki in 2012 as as a tenure track Professor.

)

University of Helsinki
Helsinki
Finland

I.F. Uchegbu (Biography
I.F. Uchegbu

Ijeoma Uchegbu is Professor of Pharmaceutical Nanoscience within the UCL School of Pharmacy. She obtained her PhD from the School of Pharmacy in 1994 and was appointed to a lectureship in Drug Delivery in 1997 within the University of Strathclyde. She became a senior lecturer in 2000 and a Professor of Drug Delivery in 2002. She then joined the School of Pharmacy as a Professor of Pharmaceutical Nanoscience in 2006 and joined UCL in 2012. In 2010 Ijeoma became cofounder Chief Scientific Officer of Nanomerics Ltd, a specialty pharmaceutical company and spin out from UCL.

)

University of Strathclyde
Glasgow
UK

K.H. Weismuller (Biography
K.H. Weismuller

Prof. Karl-Heinz Wiesmüller is the Founder of Acousia Therapeutics GmbH. Prof. Wiesmüller is a Co-founder of EMC micro collections GmbH and serves as its Chief Executive Officer. He has more than 20 years experience in combinatorial chemistry, expertise in peptide and lipopeptide synthesis and in synthetic vaccine development and immunochemistry documented in more than 170 original publications in peer-reviewed journals. He served as Head of Libraries and Screening at EVOTEC BioSystems GmbH, Hamburg and Leader of the Department of Biochemistry at the Natural & Medical Science Institute in Reutlingen. He holds a Habilitation degree in biochemistry and doctoral degree (Dr. rer. Nat.) from the University of Tübingen where he is teaching as Professor of Biochemistry.

)

EMC Microcollections GmbH
Tubingen
Germany

N. Yuksel (Biography
N. Yuksel

Professor Yuksel is a pharmacist with a research focus on pharmaceutical technology. After graduation, she worked as a pharmacist at Ministry of Health and Social Services, General Directorate of Pharmaceuticals and Pharmacy for one year, then she became a research assistant in Ankara University Faculty of Pharmacy. She got her M.Sc. degree in 1998 and Ph.D. degree in 1995 at the Department of Pharmaceutical Technology in Ankara University Faculty of Pharmacy. In 1998, she worked as a postdoc fellow in Industrial Pharmacy Program at the University of Cincinnati Faculty of Pharmacy for one year. She worked as an assistant professor between 1999-2005; obtained the title of Associate Professor in 2005; and she became a Professor in 2010. Her research interests include formulation approaches for enhancing solubility of poorly soluble drugs, development of modified release dosage forms: semisolid matrix into hard gelatin capsules, tablets, polymeric microspheres; and nanoparticulate drug delivery systems including niosomes, proniosomes, polymeric micelles. She has about 45 scientific articles and 35 symposium presentations. She has several research grants from Turkish Scientific and Technological Research Council to support her research. She is editorial board member of the journals named “Current Drug Delivery”, “Drug Delivery Letters”, and “The Scientific World Journal”. She currently serves as a member of the advisory committee for generic drug products in Turkey Drug and Medicinal Device Agency.

)

Ankara University
Ankara
Turkey

R. Alany (Biography
R. Alany

Professor Raid Alany’s academic journey spans three continents; namely, Asia, Oceania and Europe. He received his PhD in ocular drug delivery from the University of Otago, Dunedin New Zealand in 2001; was appointed as a Lecturer at the School of Pharmacy, The University of Auckland, Auckland, New Zealand, in 2001. He joined Kingston University London as Professor (Chair) of Pharmaceutics in January 2011 and was appointed as Research Director for the School of Pharmacy and Chemistry in December 2013. Dr. Raid is an author on over 200 scientific research publications (papers and abstracts), a book and seven book chapters; he has attracted over $NZ 2M (£GBP 1M) in contestable research and enterprise funding.

)

School of Pharmacy and Chemistry, Kingston University
London
UK

K.V. Barar (Biography
K.V. Barar

Dr. Kiran V. Barar is Senior Professor and HOD-Pharmacology at S.P.Medical College (SPMC), Bikaner, Rajasthan, India. She is also serving as Honorary Professor at “Albert Schiwtzer International University”(ASIU), Geneva, Switzerland since 2000. She has remained posted at RUHS-College of Medical Sciences, Jaipur (Newly recognized by MCI) for last Two years as an OSD & HOD to ESTABLISH the Dept. of Pharmacology. Dr.Kiran has been a Meritorious (Gold Medalist) throughout and Winner of various “Distinctions, Awards and Prizes” during her whole academic career. She has published about “80” papers including theses and has been an Editor, Reviewer and Writer/Columnist.

)

Rajasthan University of Health Sciences (RUHS) Bikaner
Rajasthan
India

R. Borchardt (Biography
R. Borchardt

Dr. Ronald T. Borchardt is a Distinguished Professor Emeritus of Pharmaceutical Chemistry at The University of Kansas- Lawrence. (Ph.D. in Medicinal Chemistry, 1970) from The University of Kansas-Lawrence. After serving as a Postdoctoral Fellow at the National Institutes of Health (Bethesda, Maryland) from 1969-1971. From 1983-1998, Professor Borchardt served as the Chairman of the Department of Pharmaceutical Chemistry in the School of Pharmacy at The University of Kansas. During his academic career, Professor Borchardt supervised the research of approx. 170 graduate students, postdoctoral fellows and visiting scientists. Prof. Borchardt’s research interests have included both drug delivery and drug design.

)

The University of Kansas
Lawrence, KS
USA

F. Cilurzo (Biography
F. Cilurzo

Francesco Cilurzo is associate professor in drug delivery and regulatory affairs at University of Milan, UNIMI, Department of Pharmaceutical Sciences (DISFARM), Milano.

He is promoting partner and administrator of Pharmafilm Spin-Off of the University of Milan working on the development of transdermal patches and orodispersible films.

His research work and fields of interest is based on Drug delivery, Transdemal patches, Bioadhesive dosage forms, PLGA, Permeation Enhancer. He has contributed in the publication of over 104 Research papers.

)

Università degli Studi di Milano
Milano
Italy

M. Foldvari (Biography
M. Foldvari

Prof. Marianna Foldvari is PhD. in Pharmaceutical Sciences from (Dalhousie University). She is currently working as an Associate Editor, Nanomedicine: Nanotechnology, Biology, and Medicine (2006 – Present).

Dr. Foldvari's research focuses on the development of intelligent delivery systems and biomolecular devices with the goal of developing new, non-invasive technologies to deliver and target therapeutic agents into the body and to diseased tissues, as well as investigating the fundamental properties of these delivery technologies and the cells they target.

)

University of Saskatchewan
Saskatoon, SK
Canada

R.C. Hermida (Biography
R.C. Hermida

Ramón C. Hermida is Professor and founder and director of the Laboratory of Bioengineering and Chronobiology at the University of Vigo. He was a researcher granted by the Spanish Association Against Cancer in the Faculty of Medicine of the University of Minnesota (USA) for six years, obtaining the Master's degrees in Pathology. , Cronobiology and Applied Statistics, as well as his PhD in Biomedical Engineering. He is currently President of the International Society for Chronobiology and President of the Spanish Society of Chronobiology, Chronotherapy and Vascular Risk. Prof. Hermida is the author of 80 book chapters and 260 articles in scientific journals.

)

University of Vigo
Vigo
Spain

S. K. Jain
Dr. Hari Singh Gour University
SAGAR , MP
india

M. Lane (Biography
M. Lane

Dr. Majella Lane PhD. has completed her post doctorate from Trinity College, Dublin. She is Senior Lecturer in Pharmaceutics at School of Pharmacy, University of London, United Kingdom. Dr. Lane's areas of expertise include membrane transport, biophysical approaches towards the elucidation of drug-drug, drug-excipient and drug-membrane interactions, mechanisms of drug absorption, transdermal drug delivery, topical drug delivery, percutaneous absorption, peptide and protein formulation, ungual drug absorption, buccal drug absorption. Dr Lane's major research interests are in the development of optimal drug formulations for effective delivery of therapeutics, with special reference to skin, nail and to mucus membranes.

)

School of Pharmacy, University of London
London
UK

P. Malyala (Biography
P. Malyala

Padma Malyala is currently working in Novartis Biologics Technical Development organization, Cambridge (USA) as a Biologics Expert in the Integrated Biologics Profiling group. She manages the portfolio of oncology, immuno-oncology and infectious diseases, to strategize and de-risk the development process and improve productivity by implementing platform approaches. Padma has a formal training in Pharmaceutical Sciences, followed by more than 15 years’ experience in formulation development at Medimmune, Novartis and GSK. Padma Malyala is the author of multiple patents, several original research publications and book chapters in the field of formulation, immune-potentiators and delivery systems.

)

Vaccine Chemistry & Formulations Novartis Vaccines 45 Sidney Street
Cambridge, MA
USA

R. Panchagnula (Biography
R. Panchagnula

Dr. Ramesh Panchagnula, the Managing Director of Nektar Therapeutics India Pvt. Ltd, a biopharmaceutical company, holds a DSc in Pharmaceutical Science from University of Glasgow, UK and a Ph.D in Pharmaceutics & Drug Delivery Systems from University of Cincinnati, USA. He was in academics for 20 years (USA, UK and India). He held positions of leadership in R&D and manufacturing at Pfizer then the MD of Nektar India. He has more than 25 years of research experience in Pharmaceutics, Drug Delivery/modified release systems (Small and large molecules) and Pharmaceutical Sciences and also has an extensive background in management. Dr. Panchagnula also has four patents and more than 260 publications to his credit.

)

NIPER
Punjab
India

R. Polt (Biography
R. Polt

R. Polt has embraced several relatively diverse scientific disciplines in his career, often running counter to the prevailing wisdom and advice. He studied Chemistry at IUPUI under the direction of Prof. Martin J. O’Donnell, where he was involved in the enantioselective alkylation of masked glycine anion and cation equivalents to produce the first of the “O’Donnell Schiff Bases.” (Ph2C=O + H2NCH2CO2CH2CH3 → Ph2C=NCH2CO2CH2CH3) An NSF Fellowship that took him to Columbia University where he studied with Prof. Gilbert J. Stork where he earned his Ph.D. in 1986, and then on to Prof. Dieter Seebach’s group in Zürich where he studied the alkylation of peptides in addition to glycine equivalents. Robin shifted his interests toward the synthesis and evaluation of glycopeptide drugs at the University of Arizona starting in 1988. His glycosylated neuropeptides showed excellent biological activity, extended stability in vitro and in vivo, and also cross the blood-brain barrier to produce central effects. Presently, Robin is involved in the study of glycolipid surfactants as drug delivery vehicles in addition to the glycopeptide drugs, which also possess surface activity, which is key to their distribution in vivo.

)

University of Arizona
Tucson, AZ
USA

M.A. Repka (Biography
M.A. Repka

Dr. Michael A. Repka the Chair of Pharmaceutics and Drug Delivery, also Director of the Pii Center for Pharmaceutical Technology, he is Professor of Pharmaceutics and Drug Delivery at School of Pharmacy, THE UNIVERSITY OF MISSISSIPPI , MS, USA. His research interests are “trans” systems, including transmucosal, trans-nail and transdermal drug delivery systems. Many of these systems are directed toward the delivery of poorly soluble drugs via hot-melt extrusion techniques. Polymeric drug delivery design and stabilization of conventional and novel drug delivery systems for natural product compounds such as THC, is a continued focus of research.

)

The University of Mississippi
Mississippi, MS
USA

S. Roffler (Biography
S. Roffler

Prof. Steve Roffler is currently affiliated as a research fellow with the Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. Dr. Roffler’s is Ph.D. from University of California, Berkeley. He has completed his post doctorate in Imunology from IBMS. His field of interest are monoclonal antibodies Engineering, Prodrugs, surface expression, and Directed molecular evaluation. He has contributed in above than 124 scientific publications.

)

Institute of Biomedical Sciences
Taipei
Taiwan

P. Simerská (Biography
P. Simerská

Dr Pavla Simerská is an early career researcher with experience in the field of peptide and carbohydrate chemistry, enzymatic glycosylation and vaccine/drug delivery. She received her Master degree in Biochemistry and Biomedicine from the Institute of Chemical Technology in Prague, Czech Republic in 2002. She was awarded 3 Votoček Fellowships while working on enzymatic glycosylations at the Czech Academy of Science. Pavla defended her PhD in 2006 and since then, she has been working as a Postdoctoral Research Fellow with Prof Istvan Toth at the School of Chemistry and Molecular Biosciences (SCMB), UQ. In 2010 she was awarded the Australian Postdoctoral Fellowship from the ARC.

)

The University of Queensland
Brisbane
Australia

H.C.Lutz F. Tietze
University of Goettingen TammannstraBe
Goettingen
Germany

R.B. Walker (Biography
R.B. Walker

Professor R.B. Walker completed his Ph.D. degree in Biopharmaceutics and Pharmacokinetics at Rhodes University in Grahamstown, South Africa. He is the former Dean and Head of the Faculty of Pharmacy at Rhodes and is currently the Professor of Pharmaceutics and also the current Chair of the Academy of Pharmaceutical Sciences in South Africa. Prof. Walker has published and presented over 200 scientific outputs and serves on the editorial boards of a number of journals. Professor Walker undertakes research studies in all aspects of drug delivery and product development.

)

Rhodes University
Grahamstown
South Africa

A. Williams
University of Bradford
Bradford, West Yorkshire
UK












Advertisement

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science